RNAC
NASDAQ HealthcareCartesian Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $8.12 |
|---|---|
| Volume | 100,140 |
| Market Cap | 211.15M |
| Beta | 0.230 |
| RSI (14-Day) | 58.8 |
| 200-Day MA | $9.15 |
| 50-Day MA | $7.28 |
| 52-Week High | $16.79 |
| 52-Week Low | $5.98 |
| Forward P/E | -4.80 |
| Price / Book | -1.67 |
🎯 Investment Strategy Scores
How RNAC scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
48/100
High dividend yield + low volatility
🚀 Moon Shot
7/100
High growth potential (high beta + oversold)
🔪 Falling Knife
38/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
85/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
3/100
Large-cap, institutional-quality stocks
Find RNAC in your text
Paste any text on the homepage — the tool will extract RNAC and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.